Literature DB >> 3311859

Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children.

E B Sochett1, D Daneman, C Clarson, R M Ehrlich.   

Abstract

We measured serum C-peptide, glucose, pH, islet antibodies and insulin antibody binding at diagnosis in 84 children with Type 1 (insulin-dependent) diabetes. In a subgroup of 33 children, residual insulin secretion (basal and peak C-peptide response to Sustacal), insulin antibody binding and HbA1c were measured at 10 days, 1, 3, 6 and 12 months. At presentation C-peptide correlated positively with age at onset and negatively with the blood glucose concentration. Median C-peptide concentration at diagnosis was low, rose significantly (p less than 0.05) at 10 days, reached a maximum at 1-3 months and declined gradually to 1 year. C-peptide concentration both at diagnosis and at 10 days correlated with that at 3 and 6 months. Of the factors investigated, only age (p less than 0.005) and sex (higher in females, p less than 0.01) were found to have a significant influence on basal/peak C-peptide levels throughout the first year. In particular there was no relationship between C-peptide, HbA1c and insulin dose during this period. A peak C-peptide response at 3-6 months greater than/less than 0.32 nmol/l was used to divide the group into two: 16 had a peak response less than 0.32 nmol/l (low secretors) while in 17, the peak C-peptide was greater than 0.32 nmol/l (high secretors). While the low secretors had significantly (p less than 0.05) lower C-peptide levels during the first year, there were no differences between low and high secretors in HbA1c or insulin dose.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311859     DOI: 10.1007/BF00279611

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.

Authors:  D L Horwitz; J I Starr; M E Mako; W G Blackard; A H Rubenstein
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

2.  Effects of glucose on the ultrastructure and insulin biosynthesis of isolated mouse pancreatic islets maintained in tissue culture.

Authors:  A Andersson; J Westman; C Hellerström
Journal:  Diabetologia       Date:  1974-12       Impact factor: 10.122

3.  Residual beta-cell function in children with IDDM: reproducibility of testing and factors influencing insulin secretory reserve.

Authors:  C Clarson; D Daneman; A L Drash; D J Becker; R M Ehrlich
Journal:  Diabetes Care       Date:  1987 Jan-Feb       Impact factor: 19.112

4.  Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus.

Authors:  W Gepts; J De Mey
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

5.  The early partial remission of juvenile diabetes mellitus. The roles of insulin and growth hormone.

Authors:  L Baker; R Kaye; A W Root
Journal:  J Pediatr       Date:  1967-12       Impact factor: 4.406

6.  beta-cell function in children with diabetes.

Authors:  J Ludvigsson; L G Heding
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

7.  C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control.

Authors:  J Ludvigsson; L G Heding; Y Larsson; E Leander
Journal:  Acta Paediatr Scand       Date:  1977-03

8.  Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon.

Authors:  C Hendriksen; O K Faber; J Drejer; C Binder
Journal:  Diabetologia       Date:  1977-12       Impact factor: 10.122

9.  C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide.

Authors:  R D Mirel; F Ginsberg-Fellner; D L Horwitz; E J Rayfield
Journal:  Diabetologia       Date:  1980-09       Impact factor: 10.122

10.  Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients.

Authors:  B Marner; T Agner; C Binder; A Lernmark; J Nerup; T Mandrup-Poulsen; S Walldorff
Journal:  Diabetologia       Date:  1985-12       Impact factor: 10.122

View more
  23 in total

Review 1.  Management of diabetes mellitus.

Authors:  D I Johnston
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

2.  Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis.

Authors:  A Kaas; C Pfleger; L Hansen; K Buschard; N C Schloot; B O Roep; H B Mortensen
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

3.  Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis.

Authors:  M Wallensteen; G Dahlquist; B Persson; M Landin-Olsson; A Lernmark; G Sundkvist; B Thalme
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

4.  Managing diabetes mellitus in children and adolescents: some guidelines for family physicians.

Authors:  R M Couch
Journal:  Can Fam Physician       Date:  1990-10       Impact factor: 3.275

5.  Dynamic changes in CD4+ CD25+(high) T cell apoptosis after the diagnosis of type 1 diabetes.

Authors:  S Glisic-Milosavljevic; T Wang; M Koppen; J Kramer; S Ehlenbach; J Waukau; P Jailwala; S Jana; R Alemzadeh; S Ghosh
Journal:  Clin Exp Immunol       Date:  2007-08-17       Impact factor: 4.330

6.  Persistent elevations in circulating INS DNA among subjects with longstanding type 1 diabetes.

Authors:  Anna Neyman; Jennifer Nelson; Sarah A Tersey; Raghavendra G Mirmira; Carmella Evans-Molina; Emily K Sims
Journal:  Diabetes Obes Metab       Date:  2018-08-24       Impact factor: 6.577

7.  Type 1 (insulin-dependent) diabetes in Japanese children is not a uniform disease.

Authors:  T Urakami; Y Miyamoto; H Fujita; T Kitagawa
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

Review 8.  Prevention of type 1 diabetes.

Authors:  Diane K Wherrett; Denis Daneman
Journal:  Endocrinol Metab Clin North Am       Date:  2009-12       Impact factor: 4.741

9.  Preservation of beta-cell function in autoantibody-positive youth with diabetes.

Authors:  Carla J Greenbaum; Andrea M Anderson; Lawrence M Dolan; Elizabeth J Mayer-Davis; Dana Dabelea; Giuseppina Imperatore; Santica Marcovina; Catherine Pihoker
Journal:  Diabetes Care       Date:  2009-07-08       Impact factor: 17.152

10.  New definition for the partial remission period in children and adolescents with type 1 diabetes.

Authors:  Henrik B Mortensen; Philip Hougaard; Peter Swift; Lars Hansen; Reinhard W Holl; Hilary Hoey; Hilde Bjoerndalen; Carine de Beaufort; Francesco Chiarelli; Thomas Danne; Eugen J Schoenle; Jan Aman
Journal:  Diabetes Care       Date:  2009-05-12       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.